Topic: adult pancreatic stem cells
Semma and Harvard scientists are reporting they've figured out how to regenerate high quantities of insulin-producing beta cells.
Semma Therapeutics named Bastiano Sanna, formerly of Novartis’ cell and gene therapy unit and Magenta Therapeutics, as its president and CEO.
ViaCyte and W.L. Gore will develop a delivery device for cell therapies that will protect the cells from immune rejection.